Letrozole

• Product NameLetrozole
  CAS No.112809-51-5
  Purity
  Min Quantity100Kilograms
  Price1000~
• View Contact Detail

• 
  Molecular Structure

Detailed Description

CAS : 112809-51-5
Assay:≥99.0%(HPLC)
Melting point:181℃-183℃
Molecular Formula: C17H11N5
Molecular Weight: 285.31
Appearance:White or light yellow crystal
Usage: Used as API in Treatment of breast disease.
Packing: foil bag
Payment: Bank Transfer, Western Union, Money Gram
Express: EMS, DHL, FedEx, etc(door-to-door)
Delivery: Safe & timely, around 1-3 days after payment

Description:
Femara is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
Femara is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.
Femara is used for the treatment of post-menopause breast cancer.
Femara is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body. Side effects from include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system.

ycgl01@yccreate.com
skype: echo01_5
Tel:18188938036
http://www.sellsteroids.com

• 
• Letrozole